Anticancer agents interacting with membrane glucose transporters

被引：2
|
作者：
Granchi, C. [1 ]
Fortunato, S. [1 ]
Minutolo, F. [1 ]
机构：
[1] Univ Pisa, Dipartimento Farm, Via Bonanno 33, I-56126 Pisa, Italy
来源：
MEDCHEMCOMM | 2016年 / 7卷 / 09期
基金：
美国国家卫生研究院;
关键词：
PHLORETIN-INDUCED APOPTOSIS; GLUT1 HEXOSE TRANSPORTER; BREAST-CANCER CELLS; CYTOCHALASIN-B; LUNG-CANCER; IN-VITRO; PHASE-I; BIOLOGICAL EVALUATION; SILYBIN-PHYTOSOME; CURCUMIN ANALOG;
D O I：
10.1039/c6md00287k
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The altered metabolism observed in cancer cells generally consists of increased glucose uptake and glycolytic activity. This is associated with an overexpression of glucose transporter proteins (GLUTs), which facilitate glucose uptake across the plasma membrane and play a crucial role in the survival of cancer cells. Therefore, GLUTs are considered as suitable targets for treatment of cancer. Herein we review some of the most relevant GLUT inhibitors that have been recently developed as prospective anticancer agents.
引用
收藏
页码：1716 / 1729
页数：14
相关论文
共 50 条
  • [31] Polysaccharides as potential anticancer agents-A review of their progress
    Khan, Tabassum
    Date, Amrita
    Chawda, Hardik
    Patel, Krina
    CARBOHYDRATE POLYMERS, 2019, 210 : 412 - 428
  • [32] Research Progress in the Modification of Quercetin Leading to Anticancer Agents
    Massi, Alessandro
    Bortolini, Olga
    Ragno, Daniele
    Bernardi, Tatiana
    Sacchetti, Gianni
    Tacchini, Massimo
    De Risi, Carmela
    MOLECULES, 2017, 22 (08):
  • [33] Development of 5-Fluorouracil Derivatives as Anticancer Agents
    Pan, Xiaoyan
    Wang, Chen
    Wang, Fang
    Li, Pengfei
    Hu, Zhigang
    Shan, Yuanyuan
    Zhang, Jie
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (29) : 4538 - 4556
  • [34] Chemistry and pharmacological diversity of quinoxaline motifs as anticancer agents
    Ajan, Olayinka O.
    Nlebemuo, Martins T.
    Adekoya, Joseph A.
    Ogunniran, Kehinde O.
    Siyanbola, Tolutope O.
    Ajanaku, Christiana O.
    ACTA PHARMACEUTICA, 2019, 69 (02) : 177 - 196
  • [35] Novel Derivatives of Nicotinic Acid as Promising Anticancer Agents
    Jain, Nisha
    Utreja, Divya
    Kaur, Komalpreet
    Jain, Palak
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (07) : 847 - 882
  • [36] Synthesis and characterisation of celastrol derivatives as potential anticancer agents
    Zhang, Hong-Jian
    Zhang, Guo-Rui
    Piao, Hu-Ri
    Quan, Zhe-Shan
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 33 (01) : 190 - 198
  • [37] Quinolone Derivatives as Anticancer Agents: Importance in Medicinal Chemistry
    Azzman, Nursyuhada
    Anwar, Sirajudheen
    Mohamed, Wan Ahmad Syazani
    Ahemad, Nafees
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024, 24 (13) : 1134 - 1157
  • [38] An insight into the therapeutic potential of quinazoline derivatives as anticancer agents
    Shagufta
    Ahmad, Irshad
    MEDCHEMCOMM, 2017, 8 (05) : 871 - 885
  • [39] Developments of Combretastatin A-4 Derivatives as Anticancer Agents
    Shan, Y.
    Zhang, J.
    Liu, Z.
    Wang, M.
    Dong, Y.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (04) : 523 - 538
  • [40] Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)
    Rabbani, Sayyed Mohammad Ismail Mahboubi
    Zarghi, Afshin
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2019, 29 (06) : 407 - 427
12345